Axsome Therapeutics
NY - New YorkBiotechnology
Focus: Axsome Therapeutics is a CNS-focused biotechnology company headquartered in New York specializing in neurology treatments, with a commercial-stage portfolio anchored by two marketed products generating substantial revenue.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
194+41 this month
Hot — 136 jobs added in 30d
Net +41 (136 new, 95 removed). Aggressive expansion phase.
Should You Work at Axsome Therapeutics?
AI assessmentBest fit for commercial, medical affairs, or clinical professionals seeking stability in a specialized CNS company with meaningful late-stage pipeline, but limited for those pursuing deep R&D roles or seeking diversified revenue streams.
Why Work Here
- Two marketed products (AUVELITY and SUNOSI) in peak lifecycle stages provide revenue stability and commercial execution opportunities with 132 active commercial roles.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
16 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$34M Part DGrowing
Peak
Help build intelligence for Axsome Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.